HEART FAILURE NYHA CLASS III
Clinical trials for HEART FAILURE NYHA CLASS III explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS III trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a neck implant cut heart failure deaths? new trial aims to find out
Disease control ENROLLING_BY_INVITATIONThis study tests a device called Barostim that stimulates nerves in the neck to help the body better control heart failure. It involves 2,500 adults with moderate heart failure who still have symptoms despite standard medications. The goal is to see if the device reduces deaths a…
Matched conditions: HEART FAILURE NYHA CLASS III
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Heart failure study tracks metabolic shifts from common drug
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 40 adults with heart failure to see how SGLT2 inhibitors affect their body's energy use and blood markers. Participants do a walking test, a leg MRI, and give blood samples before and after starting the drug. The goal is to understand the early metabolic change…
Matched conditions: HEART FAILURE NYHA CLASS III
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC